Literature DB >> 10657528

Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.

T Tsutsumi1, J Akiyoshi, K Isogawa, Y Kohno, T Hikichi, H Nagayama.   

Abstract

In order to examine the involvement of CCK in the formation of anxiety, we have investigated whether CCKB receptor antagonist PD135158 suppressed conditioned fear stress. Rats were individually subjected to 30 min of inescapable electric footshock in a chamber with a grid floor. First, the rats were individually subjected to 30 min of footshock. Twenty-four h after the footshock, the rats were again placed in the chamber and observed for 5 min without shocks. PD135158 was administered 30 min before placing the rats in the chamber again. Secondly, PD135158 was administered 30 min before footshock. Thirdly, PD135158 was administered 5 min after footshock. Administration of PD135158 30 min before conditioned fear stress significantly reduced freezing behavior. Administration of PD135158 30 min before footshock also significantly reduced freezing behavior. But, administration of PD135158 5 min after footshock did not significantly reduce freezing behavior. PD135158 blocked not only the acquisition but also the expression of conditioned fear. These results suggest that the CCKB receptor might play an important role in conditioned fear stress and that it might be related to anxiety. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657528     DOI: 10.1054/npep.1999.0766

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  5 in total

Review 1.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

2.  Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test.

Authors:  Sirli Raud; Jürgen Innos; Urho Abramov; Ain Reimets; Sulev Kõks; Andres Soosaar; Toshimitsu Matsui; Eero Vasar
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

3.  Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention.

Authors:  Mallory E Bowers; Kerry J Ressler
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

4.  Visuoauditory Associative Memory Established with Cholecystokinin Under Anesthesia Is Retrieved in Behavioral Contexts.

Authors:  Zicong Zhang; Xuejiao Zheng; Wenjian Sun; Yujie Peng; Yiping Guo; Danyi Lu; Yilin Zheng; Xiao Li; Peter Jendrichovsky; Peng Tang; Ling He; Min Li; Qing Liu; Fuqiang Xu; Gabriel Ng; Xi Chen; Jufang He
Journal:  J Neurosci       Date:  2020-01-24       Impact factor: 6.167

5.  Cholecystokinin from the entorhinal cortex enables neural plasticity in the auditory cortex.

Authors:  Xiao Li; Kai Yu; Zicong Zhang; Wenjian Sun; Zhou Yang; Jingyu Feng; Xi Chen; Chun-Hua Liu; Haitao Wang; Yi Ping Guo; Jufang He
Journal:  Cell Res       Date:  2013-12-17       Impact factor: 25.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.